Deciphering the role of GPCRs in obesity pathology for drug development

FHS
March 6, 2024
1:25 am

Announcing a new publication for Acta Materia Medica journal. G protein-coupled receptors (GPCRs) are important, potential drug targets for the treatment of metabolic disorders, such as obesity.

Mushroom Study: Psilocybin’s Superiority in Natural Form

The TDR Three Takeaways for the Mushroom Study: Natural mushroom extract shows greater efficacy than synthetic psilocybin in enhancing neuroplasticity. Preliminary findings suggest that mushroom

March 21, 2024

What’s Going on at Mission Health?

In Western North Carolina, controversy continues nearly 5 years after HCA Healthcare’s $1.5 billion acquisition of non-profit Mission Health in February 2019. Some 50 physicians

November 23, 2023

ADHD and Car Crashes; New Guidance on Stimulant Use Disorder Tx; KarXT Heads to FDA

Older adults with attention deficit-hyperactivity disorder (ADHD) had a significantly higher incidence of car crashes. (JAMA Network Open) Meanwhile, the estimated prevalence of ADHD in

October 5, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.